Novartis Ag NVS
NYSE NVS
$140.35 -0.58 (-0.41%)
At close: Sep 18, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Interest & Investment Income (2009 - 2018)

Novartis Ag's (NVS) quarterly Interest & Investment Income came in at $294.0 million in Q4 2018, up 488.0% quarter-over-quarter from $50.0 million in Q4 2012.

Analysis

Novartis Ag (NVS) Interest & Investment Income (2009 - 2018) Analysis & Trends

Novartis Ag has disclosed Interest & Investment Income across 5 years of filings, most recently posting $294.0 million for Q4 2018.

  • In Q4 2018, Interest & Investment Income changed N/A year-over-year to $294.0 million; the TTM figure through Dec 2018 stood at $410.0 million (changed N/A YoY), while the FY2023 annual figure was $2.0 million, down 99.47% from the prior year.
  • Interest & Investment Income came in at $294.0 million for Q4 2018 at Novartis Ag, up from $50.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $294.0 million in Q4 2018 to a low of $294.0 million in Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 219.00 Mn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -679.00 Mn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 89.50 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 35.58 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 27.90 Mn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn 38.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 294.00 Mn
Dec 31, 2012 50.00 Mn
Dec 31, 2011 62.00 Mn
Sep 30, 2011 4.00 Mn
Jun 30, 2011 -16.00 Mn
Mar 31, 2011 22.00 Mn
Dec 31, 2010 103.00 Mn
Sep 30, 2010 27.00 Mn
Jun 30, 2010 14.00 Mn
Mar 31, 2010 49.00 Mn
Dec 31, 2009 104.00 Mn
Sep 30, 2009 51.00 Mn
Jun 30, 2009 91.00 Mn
Mar 31, 2009 -48.00 Mn